Oyster Point Pharma Investor Relations Material

Oyster Point Pharma, Inc. is a biopharmaceutical company focused on developing therapies to address ophthalmic diseases. The company's primary area of focus is the treatment of dry eye disease and other ocular surface conditions. Oyster Point leverages its expertise in neuroscience and ophthalmology to develop innovative therapeutic solutions that aim to improve eye health and patient quality of life. The company serves the healthcare sector, specifically targeting the ophthalmology field with products designed to meet unmet medical needs in eye care. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.